-+ 0.00%
-+ 0.00%
-+ 0.00%

Klotho Neurosciences Seeks To Expand Into Adjacent Technologies Complementing Proprietary Anti-Aging Klotho Platform

Benzinga·07/24/2025 17:32:18
Listen to the news

Company to Pursue Technologies to Improve Muscle Strength, Bone Health, and Other Longevity Indicators

NEW YORK, July 24, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ:KLTO) (the "Company" or "Klotho") announced today that it is evaluating the acquisition of several complementary technologies aimed at supporting healthy brain function, organ health, and longevity.

In addition to its core programs targeting brain aging and neurodegenerative diseases such as ALS, Alzheimer's, and Parkinson's, the Company is now seeking to expand into adjacent technologies that complement its proprietary anti-aging Klotho platform. The goal is to slow biological aging and reduce the burden of age-related diseases—ultimately promoting a longer, healthier life.